墨西哥糖尿病视网膜病变患病率：2型糖尿病患者筛查的主要公共卫生服务倡议结果

IF 1 Q4 ENDOCRINOLOGY & METABOLISM

Diabetes epidemiology and management Pub Date : 2023-10-18 DOI:10.1016/j.deman.2023.100182

Ruben Silva-Tinoco , Dolores Cabrera-Gerardo , Lilia Castillo-Martínez , Teresa Cuatecontzi-Xochitiotzi

{"title":"墨西哥糖尿病视网膜病变患病率：2型糖尿病患者筛查的主要公共卫生服务倡议结果","authors":"Ruben Silva-Tinoco , Dolores Cabrera-Gerardo , Lilia Castillo-Martínez , Teresa Cuatecontzi-Xochitiotzi","doi":"10.1016/j.deman.2023.100182","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To estimate diabetic retinopathy (DR) prevalence in primary care scenarios in Mexico.</p></div><div><h3>Materials and methods</h3><p>We evaluated adult patients with type 2 diabetes with conventional care in primary care units. A mydriatic fundus examination was performed by an ophthalmologist with retinal photographs.</p></div><div><h3>Results</h3><p>Implementing a strategy for screening diabetic retinopathy in primary care settings in patients with type 2 diabetes in Mexico reported a prevalence of 33.6 %, comprising non-sight-threatening retinopathy at 24.2 %, and sight-threatening retinopathy at 9.4 %. The number needed to screen to detect DR obtained in the screened population was 3.</p></div><div><h3>Conclusions</h3><p>Our study reveals the need for DR screening strategies for its timely detection in primary care scenarios.</p></div>","PeriodicalId":72796,"journal":{"name":"Diabetes epidemiology and management","volume":"13 ","pages":"Article 100182"},"PeriodicalIF":1.0000,"publicationDate":"2023-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diabetic retinopathy prevalence in Mexico: Results from a primary public health access initiative for screening in patients with type 2 diabetes\",\"authors\":\"Ruben Silva-Tinoco , Dolores Cabrera-Gerardo , Lilia Castillo-Martínez , Teresa Cuatecontzi-Xochitiotzi\",\"doi\":\"10.1016/j.deman.2023.100182\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>To estimate diabetic retinopathy (DR) prevalence in primary care scenarios in Mexico.</p></div><div><h3>Materials and methods</h3><p>We evaluated adult patients with type 2 diabetes with conventional care in primary care units. A mydriatic fundus examination was performed by an ophthalmologist with retinal photographs.</p></div><div><h3>Results</h3><p>Implementing a strategy for screening diabetic retinopathy in primary care settings in patients with type 2 diabetes in Mexico reported a prevalence of 33.6 %, comprising non-sight-threatening retinopathy at 24.2 %, and sight-threatening retinopathy at 9.4 %. The number needed to screen to detect DR obtained in the screened population was 3.</p></div><div><h3>Conclusions</h3><p>Our study reveals the need for DR screening strategies for its timely detection in primary care scenarios.</p></div>\",\"PeriodicalId\":72796,\"journal\":{\"name\":\"Diabetes epidemiology and management\",\"volume\":\"13 \",\"pages\":\"Article 100182\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2023-10-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes epidemiology and management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666970623000616\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes epidemiology and management","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666970623000616","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

摘要

目的评估墨西哥初级保健方案中糖尿病视网膜病变（DR）的患病率。材料和方法我们评估了在初级保健病房接受常规护理的成年2型糖尿病患者。眼科医生用视网膜照片进行了眼底散瞳检查。结果墨西哥2型糖尿病患者在初级保健环境中实施糖尿病视网膜病变筛查策略的患病率为33.6%，和9.4%的视力威胁性视网膜病变。在筛查人群中检测DR所需的筛查数量为3。结论我们的研究揭示了在初级保健场景中及时检测DR筛查策略的必要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Diabetic retinopathy prevalence in Mexico: Results from a primary public health access initiative for screening in patients with type 2 diabetes

Objective

To estimate diabetic retinopathy (DR) prevalence in primary care scenarios in Mexico.

Materials and methods

We evaluated adult patients with type 2 diabetes with conventional care in primary care units. A mydriatic fundus examination was performed by an ophthalmologist with retinal photographs.

Results

Implementing a strategy for screening diabetic retinopathy in primary care settings in patients with type 2 diabetes in Mexico reported a prevalence of 33.6 %, comprising non-sight-threatening retinopathy at 24.2 %, and sight-threatening retinopathy at 9.4 %. The number needed to screen to detect DR obtained in the screened population was 3.